Cyclerion Therapeutics
CYCN • NASDAQ
Cyclerion Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Regina Graul, with a market cap of $13.7M.
Market Cap$13.7M
Employees1.0
CEORegina Graul
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Cyclerion Therapeutics FAQ
Common questions about Cyclerion Therapeutics
Cyclerion Therapeutics is scheduled to report earnings for Q1 2026 on May 5, 2026.
Cyclerion Therapeutics has approximately 1 employees.